Please note that not all cases of disease or outbreaks are reported; some outbreaks may only be reported if they occur outside of the usual recognised risk area or season, or they have been reported in greater than usual numbers. See 'About Outbreaks' tab below for further detail.
For further information on red, amber and green alert categories, see About Outbreaks tab.
Yellow fever in Côte d'Ivoire
As of 23 September 2026, 30 confirmed yellow fever cases (10 deaths) have been reported during 2026 across seven regions. The Bounkani Region has reported 18 of these cases. Please see our Topics in Brief article for further details on yellow fever.
As of 14 October 2026, a total of 23 yellow fever cases, with 11 deaths, have now been reported in Côte d'Ivoire for 2026. An outbreak response, including an emergency vaccination campaign, is ongoing. Please see our Topics in Brief article for further details on yellow fever.
Source: StateBetween 1 January and 23 August 2026, a total of 14 yellow fever cases, with two deaths, have been reported in eight health districts of Côte d'Ivoire. Please see our Topics in Brief article for further details on yellow fever.
Source: WHOEbola disease in United Kingdom ex DRC
A UK medical doctor who was working on the Ebola epidemic in the Democratic Republic of the Congo (DRC) has returned to the UK for specialist treatment after testing positive for the disease. The UK Health Security Agency have stated that the risk to the wider public remains low. Please see our Topics in Brief article for further details on Ebola disease.
Measles in USA
On 5 November 2026, the Wisconsin Department of Health Services reported a death in an infant, linked to the ongoing measles outbreak in southwestern Wisconsin. This is the first measles-associated death reported in Wisconsin since 1990. As of 3 November, 431 meases cases across 13 counties in Wisconsin have been reported in 2026. Please see our Topics in Brief article for further details on measles.
As of 23 October 2026, 4,588 confirmed measles cases have been reported across 47 states/jurisdictions in the United States, during 2026. This exceeds the number of cases reported for the whole of 2025 and is the highest number of measles cases reported in the US for 35 years. The highest number of cases have been reported in Pennsylvania (1,327), followed by South Carolina (670) and Utah (535). Please see our Topics in Brief article for further details on measles.
Source: CDCAs of 24 September 2026, 3,659 confirmed measles cases have been reported across 47 states in the United States, during 2026. This exceeds the number of cases reported for the whole of 2025 and is the highest number of measles cases reported in the US for 35 years. The highest number of cases have been reported in Pennsylvania (850), followed by South Carolina (670) and Utah (535). Please see our Topics in Brief article for further details on measles.
Source: CDCAs of 23 July 2026, a total of 2,318 confirmed measles cases have been reported across 45 states of the United States in 2026. This exceeds the number of cases reported for the whole of 2025 and is the highest number of measles cases reported in the US for 35 years. Please see our Topics in Brief article for further details on measles.
Source: CDCOccitanie
Île-de-France
Auvergne-Rhône Alpes
Provence Alpes-Côte d’Azur
Chikungunya in France
As of 2 November 2026, a total of 208 locally acquired chikungunya cases have been reported during 2026 in Tarn, Lot, Gard (Occitanie), Gironde, Landes, Pyrenees-Atlantiques (Nouvelle-Aquitaine), Val-de-Marne, Seine-Saint-Denis (Île-de-France), Var (Provence-Alpes-Cote d'Azur) and Drôme (Auvergne-Rhône-Alpes) in France. Please see our Topics in Brief article for further details on chikungunya.
As of 12 October 2026, a total of 162 locally acquired chikungunya cases have been reported during 2026 in Tarn, Lot, Gard (Occitanie), Gironde, Landes, Pyrenees-Atlantiques (Nouvelle-Aquitaine), Val-de-Marne (Île-de-France) and Var (Provence-Alpes-Cote d'Azur) in France. Please see our Topics in Brief article for further details on chikungunya.
Source: StateAs of 5 October 2026, a total of 146 locally acquired chikungunya cases have been reported during 2026 in Tarn, Lot (Occitanie), Gironde (Nouvelle-Aquitaine), Val-de-Marne (Île-de-France) and Var (Provence-Alpes-Cote d'Azur) in France. Please see our Topics in Brief article for further details on chikungunya.
Source: StateAs of 28 September 2026, 125 locally acquired cases of chikungunya have been identified in France, in Tarn, Lot, Gard (Occitanie), Gironde, Landes (Nouvelle-Aquitaine), Val-de-Marne (Ile-de-France) and Var (Provence-Alpes-Cote d'Azur). Please see our Topics in Brief article for further details on chikungunya.
Source: StateAs of 23 September 2026, 90 autochthonous cases of chikungunya have been identified in France, in Tarn, Lot (Occitanie), Gironde, Landes (Nouvelle-Aquitaine) and Val-de-Marne (Ile-de-France). Please see our Topics in Brief article for further details on chikungunya.
Source: StateAs of 9 September 2026, a total of 57 locally acquired chikungunya cases have been reported during 2026 in Tarn, Lot (Occitanie), Gironde (Nouvelle-Aquitaine) and Val-de-Marne (Île-de-France) in France. Please see our Topics in Brief article for further details on chikungunya.
Source: ECDCAs of 30 August 2026, a total of 46 locally acquired chikungunya cases have been reported during 2026 in Tarn, Lot (Occitanie), Gironde (Nouvelle-Aquitaine) and Val-de-Marne (Île-de-France) in France. Please see our Topics in Brief article for further details on chikungunya.
Source: StateAs of 26 August 2026, a total of 33 locally acquired chikungunya cases have been reported during 2026 in the Nouvelle-Aquitaine (Gironde), Occitanie (Tarn, Lot) and Île-de-France (Val-de-Marne) regions of France. Please see our Topics in Brief article for further details on chikungunya.
Source: StateAs of 17 August 2026, a total of 25 locally acquired chikungunya cases have been reported during 2026 in the Nouvelle-Aquitaine (Gironde) and Occitanie (Tarn) regions of France. Please see our Topics in Brief article for further details on chikungunya.
Source: StateAs of 10 August 2026, a total of 15 locally acquired chikungunya cases have been reported during 2026 in the Nouvelle-Aquitaine (Gironde) and Occitanie (Tarn) regions of France. Please see our Topics in Brief article for further details on chikungunya.
Source: StateAs of 3 August 2026, seven locally acquired cases of chikungunya have been reported in Tam (Occitanie) and Gironde (Nouvelle-Aquitaine). Please see our Topics in Brief article for further details on chikungunya.
Source: StateAs of 27 July 2026, a locally acquired case of chikungunya has been reported in the Tam region, Occitanie. This is the first locally acquired chikungunya case in mainland France in 2026. Please see our Topics in Brief article for further details on chikungunya.
Source: StateShamonda virus in France
On 2 November 2026, World Health Organization (WHO) published an update following the first ever known case of Shamonda virus (SHAV) infection in a human. The case was an immunocompromised older man from eastern France with no travel history during the preceding year. He developed severe encephalitis (brain inflammation) and died in early October 2026. Vector-borne transmission (via a bite from an infected midge) is thought to be the most likely source of infection. Food-borne transmission is unlikely but remains under investigation. As this is the first documented laboratory confirmed human infection, WHO considers that the public health risk cannot yet be reliably assessed and recommends continued surveillance and investigation.
On 22 October 2026, French health authorities reported the first ever known case of Shamonda virus (SHAV) infection in a human. The case was severely immunosuppressed and died in early October. Some brain complications prior to his death were likely linked to the infection. It is thought that the individual contracted the virus following a bite from a midge in the East of France, where the virus has been been circulating in animals (mainly cattle) since spring/summer 2026. Local health authorities have advised there is no risk to the general population at present as this appears to be an isolated and exceptional case. Please see World Organisation for Animal Health for further details on Shamonda virus.
Source: StateWest Nile virus in USA
As of 3 November 2026, a total of 1,668 human cases of West Nile virus have been reported across 47 states in the United States. Of these, 1,285 cases were reported to be the neuroinvasive form. The highest number of cases were reported in California (452 cases), Arizona (112), and Texas (91 cases). Please see our Topics in Brief article for further details on West Nile virus.
As of 13 October, a total of 1,328 human cases of West Nile virus have been reported across 45 states in the United States. Of these, 1,004 cases were reported to be the neuroinvasive form. The highest number of cases were reported in California (310 cases), Arizona (95), and Texas (80 cases). Please see our Topics in Brief article for further details on West Nile virus.
Source: CDCAs of 1 September 2026, a total of 407 human cases of West Nile virus have been reported across 40 states in the United States. Of these, 285 cases were reported to be the neuroinvasive form. The highest number of cases have been reported in Arizona (88 cases), California (66 cases) and Texas (46 cases). Please see our Topics in Brief article for further details on West Nile virus.
Source: CDCAs of 11 August 2026, a total of 181 human cases of West Nile virus have been reported across 30 states in the United States this year. Of these, 129 cases were reported to be the neuroinvasive form. The highest number of cases have been reported in Arizona (73 cases), Texas (23 cases), and California (18 cases). Please see our Topics in Brief article for further details on West Nile virus.
Source: StateWest Nile virus in Slovakia
As of 28 October 2026, the first case of West Nile virus of 2026 has been reported in Trnavský kraj, Slovakia. Please see our Topics in Brief article for further details on West Nile virus.
Yellow fever in Burkina Faso
As of 27 October 2026, a total of 15 yellow fever cases, with three deaths, have been reported in Burkina Faso for 2026. Please see our Topics in Brief article for further details on yellow fever.
Dengue in Colombia
As of 17 October 2026, a total of 91,419 dengue cases (64, 333 confirmed) and 69 deaths have now been reported in Columbia during 2026. Serotypes DENV-1, DENV-2, DENV-3 and DENV-4 have been identified. Please see our Topics in Brief article for further details on dengue.
As of 25 January 2026, 9,383 suspected cases (two deaths) of dengue have been reported in Colombia since the start of the year. Case numbers usually increase during the first few months of the year. A total of 125,119 cases (124 deaths) were reported during 2025. Serotypes DENV-1, DENV-2, DENV-3 and DENV-4 were all reported. Please see our Topics in Brief article for further details on dengue.
Source: PAHOAs of 6 September 2025, a total of 101,523 dengue cases have been reported in Colombia for 2025. Please see our Topics in Brief article for further details on dengue.
Source: PAHOAs of 10 July 2025, a total of 83,083 confirmed dengue cases have been reported in Colombia for 2025. Please see our Topics in Brief article for further details on dengue.
Source: PAHOAs of 10 August 2024, a total of 243,146 cases of dengue have been reported since the beginning of the year. This represents a significant increase in the reporting of dengue cases compared to the last few years. All four dengue serogroups (DENV1-4) are in circulation.
Source: StateColombia reported 112,140 cases of dengue between 1 January 2024 and 26 April 2024, representing an increase of 373% compared to the same period in 2023. The cumulative incidence rate as of 26 April 2024 is 219 cases per 100,000 population.
Source: PAHOYellow fever in Ghana
As of 19 October 2026, a total of 121 yellow fever cases (19 confirmed), with three deaths, have now been reported in the Upper West Region of Ghana. The outbreak response, including an emergency vaccination campaign, continues. Please see our Topics in Brief article for further details on yellow fever.
As of 11 October 2026, 43 suspected cases (including three confirmed deaths) of yellow fever have been reported in the Upper West Region. Case numbers appear to peak in mid September. Monitoring in the region continues. Please see our Topics in Brief article for further details on yellow fever.
Source: WHOAs of 8 October 2026, Ghana's Ministry of Health has reported three confirmed fatal yellow fever cases in Upper West Region. An emergency response, including deployment of rapid response teams and a targeted vaccination campaign, is ongoing. Please see our Topics in Brief article for further details on yellow fever.
Source: StateNaTHNaC regularly review and update information on disease outbreaks and other health issues that may affect the UK traveller. You can search the information by disease or by country in our Outbreak Surveillance section.
The information comes from a wide variety of sources and can be used along with the Country Information section of our website where you will find recommendations on vaccines, malaria and other risks for each country (where relevant).
Please note that not all cases of disease or outbreaks are reported. In some countries, there may be limited surveillance and reporting processes in place so information can be difficult to obtain. Some diseases may only be reported if they occur outside of the usual recognised risk area or season, or they have been reported in greater than usual numbers. Outbreaks of those diseases included in the UK childhood vaccination programme are not usually reported unless the outbreak is unusual or unexpected.
The information presented in the disease surveillance reports is collated from a variety of sources, including government bodies, international organisations and the media. The verification status of each report is clearly indicated. Verified reports are confirmed by official sources. Some unverified reports are included to ensure timely dissemination of information and where possible we will try to substantiate these reports, although confirmation may not always be possible. Unverified reports may be subject to change, misreporting and may later prove to be unsubstantiated. They should not therefore be regarded as official.
Where available, a web link is provided to the original information source. We cannot accept responsibility for the sites to which it links, or for the information found on those sites. Linking to outside sites does not in any way imply endorsement of these sites. If you wish to use the following content for official purposes, please refer to the original sources of information.
Key to NaTHNaC alert level feature
LEVEL 1: GREEN |
Take usual precautions
|
Follow standard protective measures, as recommended for this destination, disease or situation. Be aware that advice may change and check for updates. |
|
LEVEL 2: AMBER |
Take extra precautions
|
Follow any additional precautions recommended. Be alert and check regularly for changes in advice about this ongoing situation. Advice may be relevant for all travellers or apply to a specific group of travellers. |
|
LEVEL 3: RED |
FCDO advise against travel
|
The Foreign, Commonwealth & Development Office (FCDO) advise against travel on health grounds. This may mean avoiding non-essential travel, or all travel, follow the FCDO advice for details. Please note we do not report on FCDO safety and security alerts. Travellers should check the FCDO travel advisories for their destination for this information. |
|
Alert categories are based on the situation at the time of publication. They will not be routinely updated unless outbreak information or a news item is updated.
